Sino Biopharm To Remain Active in M&A, Says Chair

Sino Biopharm To Remain Active in M&A, Says Chair



Sino Biopharm To Remain Active in M&A, Says Chair
Sino Biopharmaceutical Chairwoman Theresa Tse says her company is open to acquiring more biotech companies in China after announcing a new buyout. She also tells “Bloomberg: The China Show” that the company is looking for partnerships with bigger multinational firms. (Source: Bloomberg)


www.bloomberg.com
#Sino #Biopharm #Remain #Active #MampA #Chair

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *